These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9790104)
1. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma. Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104 [TBL] [Abstract][Full Text] [Related]
2. Estimation of the volume-weighted mean nuclear volume discriminates Spitz's nevi from nodular malignant melanomas. Steiner A; Binder M; Mossbacher U; Wolff K; Pehamberger H Lab Invest; 1994 Mar; 70(3):381-5. PubMed ID: 8145531 [TBL] [Abstract][Full Text] [Related]
3. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas. Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912 [TBL] [Abstract][Full Text] [Related]
4. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis. Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833 [TBL] [Abstract][Full Text] [Related]
6. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients. Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039 [TBL] [Abstract][Full Text] [Related]
7. Keratoacanthoma: Update on the Debate. Nirenberg A; Steinman H; Dixon A Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044 [TBL] [Abstract][Full Text] [Related]
8. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Cain CT; Niemann TH; Argenyi ZB Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793 [TBL] [Abstract][Full Text] [Related]
9. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma]. Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864 [TBL] [Abstract][Full Text] [Related]
11. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Cribier B; Asch P; Grosshans E Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399 [TBL] [Abstract][Full Text] [Related]
12. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454 [TBL] [Abstract][Full Text] [Related]
13. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258 [TBL] [Abstract][Full Text] [Related]
14. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma. Binder M; Dolezal I; Wolff K; Pehamberger H J Invest Dermatol; 1992 Aug; 99(2):180-3. PubMed ID: 1629630 [TBL] [Abstract][Full Text] [Related]
15. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma. Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840 [TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin. Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390 [TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. Phillips P; Helm KF J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945 [TBL] [Abstract][Full Text] [Related]
18. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma. Korenberg R; Penneys NS; Kowalczyk A; Nadji M J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786 [TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827 [TBL] [Abstract][Full Text] [Related]
20. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions. Takai T; Misago N; Murata Y J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]